Literature DB >> 27752657

A general synthesis of arylindoles and (1-arylvinyl)carbazoles via a one-pot reaction from N-tosylhydrazones and 2-nitro-haloarenes and their potential application to colon cancer.

Tourin Bzeih1, Timothée Naret2, Ali Hachem3, Nada Jaber3, Ali Khalaf3, Jerome Bignon4, Jean-Daniel Brion2, Mouad Alami2, Abdallah Hamze2.   

Abstract

A convergent and effective synthesis of 3-aryl-indoles, 2,3-diaryl indoles, and (1-arylvinyl)carbazoles from a one-pot sequence involving the coupling of N-tosylhydrazones with ortho-nitro-haloarenes followed by a cyclization has been developed. Compound 5i exhibits excellent antiproliferative activity in the low nM range against colon cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27752657     DOI: 10.1039/c6cc07666a

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  4 in total

Review 1.  Recent advances in combretastatin based derivatives and prodrugs as antimitotic agents.

Authors:  Zaki S Seddigi; M Shaheer Malik; A Prasanth Saraswati; Saleh A Ahmed; Ahmed O Babalghith; Hawazen A Lamfon; Ahmed Kamal
Journal:  Medchemcomm       Date:  2017-07-04       Impact factor: 3.597

2.  A palladium-catalyzed Barluenga cross-coupling - reductive cyclization sequence to substituted indoles.

Authors:  S M Ashikur Rahman; Björn C G Söderberg
Journal:  Tetrahedron       Date:  2021-07-06       Impact factor: 2.388

Review 3.  Target-based anticancer indole derivatives and insight into structure‒activity relationship: A mechanistic review update (2018-2021).

Authors:  Ashima Dhiman; Rupam Sharma; Rajesh K Singh
Journal:  Acta Pharm Sin B       Date:  2022-04-01       Impact factor: 14.903

4.  Design, synthesis and biological evaluation of 9-aryl-5H-pyrido[4,3-b]indole derivatives as potential tubulin polymerization inhibitors.

Authors:  Lingyu Shi; Shanbo Yang; Jing Chang; Yujing Zhang; Wenjing Liu; Jun Zeng; Jingsen Meng; Renshuai Zhang; Chao Wang; Dongming Xing
Journal:  Front Chem       Date:  2022-09-15       Impact factor: 5.545

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.